In this review:
Necrobiosis lipoidica and malignancy
Ixekizumab vs secukinumab, adalimumab, ustekinumab, and etanercept for psoriasis
Bimekizumab for moderate-to-severe scalp psoriasis
Continuous risankizumab for moderate-to-severe psoriasis
Baricitinib improves sleep and QOL in moderate-to-severe atopic dermatitis
Effects of upadacitinib on symptoms of atopic dermatitis
Abrocitinib for moderate-to-severe atopic dermatitis refractory to dupilumab
Prognostic outcomes in cutaneous SCC with and without perineural invasion
Vitiligo and metabolic syndrome
Hidradenitis suppurativa and association with stroke
Results from the HS UNITE Registry
Comparative effectiveness of acne scar treatments
Please login below to download this issue (PDF)